| Nanotechnology approaches for global infectious diseases AR Kirtane, M Verma, P Karandikar, J Furin, R Langer, G Traverso Nature Nanotechnology 16 (4), 369-384, 2021 | 396 | 2021 |
| Exploiting nanotechnology to overcome tumor drug resistance: challenges and opportunities AR Kirtane, SM Kalscheuer, J Panyam Advanced drug delivery reviews 65 (13-14), 1731-1747, 2013 | 272 | 2013 |
| Folic acid functionalized nanoparticles for enhanced oral drug delivery E Roger, S Kalscheuer, A Kirtane, BR Guru, AE Grill, J Whittum-Hudson, ... Molecular pharmaceutics 9 (7), 2103-2110, 2012 | 196 | 2012 |
| Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy AR Kirtane, O Abouzid, D Minahan, T Bensel, AL Hill, C Selinger, ... Nature communications 9 (1), 1-12, 2018 | 161 | 2018 |
| Triggerable tough hydrogels for gastric resident dosage forms J Liu, Y Pang, S Zhang, C Cleveland, X Yin, L Booth, J Lin, YA Lucy Lee, ... Nature communications 8 (1), 124, 2017 | 150 | 2017 |
| Computationally guided high-throughput design of self-assembling drug nanoparticles D Reker, Y Rybakova, AR Kirtane, R Cao, JW Yang, N Navamajiti, ... Nature nanotechnology 16 (6), 725-733, 2021 | 103 | 2021 |
| 3D‐printed gastric resident electronics YL Kong, X Zou, CA McCandler, AR Kirtane, S Ning, J Zhou, A Abid, ... Advanced Materials Technologies 4 (3), 1800490, 2019 | 100 | 2019 |
| Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer … S Arora, SK Swaminathan, A Kirtane, SK Srivastava, A Bhardwaj, S Singh, ... International journal of nanomedicine, 2933-2942, 2014 | 97 | 2014 |
| Weighing up gene delivery AR Kirtane, J Panyam Nature nanotechnology 8 (11), 805-806, 2013 | 72 | 2013 |
| Temperature-responsive biometamaterials for gastrointestinal applications S Babaee, S Pajovic, AR Kirtane, J Shi, E Caffarel-Salvador, K Hess, ... Science translational medicine 11 (488), eaau8581, 2019 | 70 | 2019 |
| Oral mRNA delivery using capsule-mediated gastrointestinal tissue injections A Abramson, AR Kirtane, Y Shi, G Zhong, JE Collins, S Tamang, K Ishida, ... Matter 5 (3), 975-987, 2022 | 61 | 2022 |
| Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling JM Song, K Molla, A Anandharaj, I Cornax, MG OSullivan, AR Kirtane, ... Oncotarget 8 (16), 26927, 2017 | 57 | 2017 |
| Enhanced photodynamic therapy and effective elimination of cancer stem cells using surfactant–polymer nanoparticles M Usacheva, SK Swaminathan, AR Kirtane, J Panyam Molecular pharmaceutics 11 (9), 3186-3195, 2014 | 55 | 2014 |
| Genotype-targeted local therapy of glioma GM Shankar, AR Kirtane, JJ Miller, H Mazdiyasni, J Rogner, T Tai, ... Proceedings of the National Academy of Sciences 115 (36), E8388-E8394, 2018 | 52 | 2018 |
| Gastrointestinal synthetic epithelial linings J Li, T Wang, AR Kirtane, Y Shi, A Jones, Z Moussa, A Lopes, J Collins, ... Science translational medicine 12 (558), eabc0441, 2020 | 51 | 2020 |
| Changing the pill: developments toward the promise of an ultra-long-acting gastroretentive dosage form DH Altreuter, AR Kirtane, T Grant, C Kruger, G Traverso, AM Bellinger Expert opinion on drug delivery 15 (12), 1189-1198, 2018 | 49 | 2018 |
| Machine learning uncovers food-and excipient-drug interactions D Reker, Y Shi, AR Kirtane, K Hess, GJ Zhong, E Crane, CH Lin, ... Cell reports 30 (11), 3710-3716. e4, 2020 | 47 | 2020 |
| A once-a-month oral contraceptive AR Kirtane, T Hua, A Hayward, A Bajpayee, A Wahane, A Lopes, ... Science Translational Medicine 11 (521), eaay2602, 2019 | 47 | 2019 |
| Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer V Khanna, S Kalscheuer, A Kirtane, W Zhang, J Panyam Future drug discovery 1 (1), FDD8, 2019 | 42 | 2019 |
| Local Targeting of NAD+ Salvage Pathway Alters the Immune Tumor Microenvironment and Enhances Checkpoint Immunotherapy in Glioblastoma M Li, AR Kirtane, J Kiyokawa, H Nagashima, A Lopes, ZA Tirmizi, CK Lee, ... Cancer Research 80 (22), 5024-5034, 2020 | 41 | 2020 |
Giovanni TraversoMIT; Brigham and Women's Hospital, Harvard Medical School; Broad InstituteVerified email at mit.edu
